0M3Q Stock Overview Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Price History & Performance
Summary of share price highs, lows and changes for Zoetis Historical stock prices Current Share Price US$167.60 52 Week High US$200.29 52 Week Low US$144.82 Beta 0.89 1 Month Change 1.49% 3 Month Change -11.31% 1 Year Change -11.16% 3 Year Change -14.06% 5 Year Change 23.27% Change since IPO 109.26%
Recent News & Updates
Upcoming dividend of US$0.50 per share Jan 14
Third quarter dividend increased to US$0.50 Dec 16
Zoetis Declares First Quarter 2025 Dividend, Payable on March 4, 2025 Dec 13
Zoetis Inc. Announces Executive Changes Nov 11
Zoetis Inc. Raises Revenue Guidance for the Full Year 2024 Nov 05
Third quarter 2024 earnings released: EPS: US$1.51 (vs US$1.30 in 3Q 2023) Nov 04 See more updates
Upcoming dividend of US$0.50 per share Jan 14
Third quarter dividend increased to US$0.50 Dec 16
Zoetis Declares First Quarter 2025 Dividend, Payable on March 4, 2025 Dec 13
Zoetis Inc. Announces Executive Changes Nov 11
Zoetis Inc. Raises Revenue Guidance for the Full Year 2024 Nov 05
Third quarter 2024 earnings released: EPS: US$1.51 (vs US$1.30 in 3Q 2023) Nov 04
Second quarter dividend of US$0.43 announced Oct 13
Zoetis Inc. Declares Fourth Quarter 2024 Dividend, Payable on December 3, 2024 Oct 11
Zoetis to Introduce First Cartridge-Based AI-Powered Hematology Analyzer Sep 17
Second quarter 2024 earnings released: EPS: US$1.37 (vs US$1.45 in 2Q 2023) Aug 07
Zoetis Inc. Raises Earnings Guidance for the Year 2024 Aug 07 Zoetis Inc. (NYSE:ZTS) announces an Equity Buyback for $6,000 million worth of its shares. Aug 02
Upcoming dividend of US$0.43 per share Jul 11
First quarter dividend of US$0.43 announced May 27
Zoetis Inc. Announces Retirement of Linda Rhodes as Board of Directors May 25
Zoetis Inc. Declares Dividend for the Third Quarter of 2024, Payable on September 4, 2024 May 23
Zoetis Inc. Revises Earnings Guidance for the Year 2024 May 03
First quarter 2024 earnings released: EPS: US$1.31 (vs US$1.19 in 1Q 2023) May 02
Phibro Animal Health Corporation (NasdaqGM:PAHC) entered into a definitive agreement to acquire Medicated feed additive product portfolio, certain water soluble products and related assets of Zoetis Inc. (NYSE:ZTS) for approximately $350 million. Apr 30
Zoetis Inc. Announces Executive Changes Apr 17
Now 24% undervalued after recent price drop Apr 13
Zoetis Inc., Annual General Meeting, May 22, 2024 Apr 11
Upcoming dividend of US$0.43 per share Apr 11
Zoetis Inc. Appoints Gavin D.K. Hattersley to Its Board of Directors Apr 02
Now 20% undervalued after recent price drop Mar 27
Full year 2023 earnings released: EPS: US$5.08 (vs US$4.51 in FY 2022) Feb 13
Dividend of US$0.43 announced Feb 12
Zoetis Inc. Declares Second Quarter 2024 Dividend, Payable on June 4, 2024 Feb 07
Upcoming dividend of US$0.43 per share at 0.9% yield Jan 11
Insufficient new directors Jan 01
Zoetis Inc. Declares Dividend for the First Quarter of 2024, Payable on March 1, 2024 Dec 08
Zoetis Inc. Provides Earnings Guidance for the Full Year 2023 Nov 03
Third quarter 2023 earnings released: EPS: US$1.30 (vs US$1.13 in 3Q 2022) Nov 02
Upcoming dividend of US$0.38 per share at 0.9% yield Oct 24
Zoetis Inc. Declares Dividend for the Fourth Quarter of 2023, Payable on December 1, 2023 Oct 13 Zoetis Inc. (NYSE:ZTS) acquired adivo GmbH from founders, High-Tech Gründerfonds, the Swiss Occident Group AG and MorphoSys AG (XTRA:MOR). Sep 17
Zoetis Inc. (NYSE:ZTS) acquired adivo GmbH. Sep 16
Second quarter 2023 earnings released: EPS: US$1.45 (vs US$1.13 in 2Q 2022) Aug 09
Upcoming dividend of US$0.38 per share at 0.9% yield Jul 13
Zoetis Inc. Announces Appointment of Ester Banque as Executive Vice President and President, U.S. Operations Jul 11
JAB Holdings B.V. acquired an unknown majority interest in Pumpkin Insurance Services Inc. from Zoetis Inc. (NYSE:ZTS). May 17
Zoetis Inc. Declares Dividend for Third Quarter of 2023, Payable on September 1, 2023 May 12
Zoetis Inc. Announces U.S. Food and Drug Administration Approves Librela™ (Bedinvetmab Injection) for Control of Pain Associated with Osteoarthritis in Dogs May 06
Zoetis Inc. Maintains Earnings Guidance for the Full Year 2023 May 05
First quarter 2023 earnings released: EPS: US$1.19 (vs US$1.26 in 1Q 2022) May 05
Upcoming dividend of US$0.38 per share at 0.9% yield Apr 13
Zoetis Inc. Provides Earning Guidance for Full Year 2023 Feb 15
Full year 2022 earnings released: EPS: US$4.51 (vs US$4.29 in FY 2021) Feb 14
Zoetis Inc. Declares Second Quarter 2023 Dividend, Payable on June 1, 2023 Feb 09
Zoetis Inc. Announces Termination of Glenn David as Executive Vice President and Group President, U.S. Operations Feb 08
Upcoming dividend of US$0.38 per share Jan 12
Now 21% undervalued after recent price drop Jan 05
Zoetis Inc. Declares Dividend for the First Quarter of 2023 Dividend, Payable on March 1, 2023 Dec 09
Third quarter 2022 earnings released: EPS: US$1.13 (vs US$1.17 in 3Q 2021) Nov 04
Zoetis Inc. Provides Earnings Guidance for the Full Year 2022 Nov 04
Zoetis Inc. Announces Management Changes, Effective November 1, 2022 Oct 27
Upcoming dividend of US$0.33 per share Oct 24
Zoetis Inc. Declares Dividend for the Fourth Quarter of 2022, Payable on December 1, 2022 Oct 14
Second quarter 2022 earnings released: EPS: US$1.13 (vs US$1.08 in 2Q 2021) Aug 05
Zoetis Inc. Provides Earnings Guidance for the Full Year 2022 Aug 05
Zoetis Inc. Appoints Vanessa Broadhurst to Its Board of Directors Jul 26
Now 21% undervalued Jul 25
Upcoming dividend of US$0.33 per share Jul 13
Now 21% undervalued after recent price drop Jun 30
Zoetis Inc.(NYSE:ZTS) dropped from Russell 1000 Value-Defensive Index Jun 26
Zoetis Inc. (NYSE:ZTS) acquired Basepaws Jun 23
Independent Director recently sold US$301k worth of stock Jun 15
Zoetis Inc. (NYSE:ZTS) entered into an agreement to acquire Basepaws. Jun 08
Now 23% undervalued after recent price drop Jun 01
Zoetis Inc. Declares Dividend for the Third Quarter of 2022, Payable on September 1, 2022 May 20
First quarter 2022 earnings released: EPS: US$1.26 (vs US$1.18 in 1Q 2021) May 06 Zoetis Inc. Revises Earnings Guidance for the Year 2022
Now 22% undervalued after recent price drop May 03
Zoetis Inc. Announces Retirement of Roman Trawicki as Executive Vice President and President, Effective July 31, 2022 Apr 22
Upcoming dividend of US$0.33 per share Apr 13
Zoetis Inc., Annual General Meeting, May 19, 2022 Apr 07
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Feb 16
Zoetis Inc. Provides Earnings Guidance for the Full Year 2022 Feb 16
Zoetis Inc. Declares Dividend for the Second Quarter 2022, Payable on June 1, 2022 Feb 09
Zoetis Inc. Announces FDA Approval of Solensia™ (frunevetmab injection) to Control Osteoarthritis Pain in Cats Jan 14
Upcoming dividend of US$0.33 per share Jan 12
Zoetis Inc. (NYSE:ZTS) announces an Equity Buyback for $3,500 million worth of its shares. Dec 08
CEO & Director recently sold US$562k worth of stock Dec 01
Independent Director recently sold US$972k worth of stock Nov 11
Third quarter 2021 earnings released: EPS US$1.17 (vs US$1.01 in 3Q 2020) Nov 06
Upcoming dividend of US$0.25 per share Oct 21
Insider recently sold US$235k worth of stock Oct 05
Key Executive recently sold US$1.2m worth of stock Aug 25
Zoetis Inc. Provides Earnings Guidance for Full Year 2021 Aug 08
Second quarter 2021 earnings released: EPS US$1.08 (vs US$0.79 in 2Q 2020) Aug 06
Zoetis Inc. (NYSE:ZTS) entered into an agreement to acquire Jurox Pty Limited from O’Brien family. Aug 06
Key Executive recently sold US$1.9m worth of stock Jul 27
Upcoming dividend of US$0.25 per share Jul 14
Insider recently sold US$226k worth of stock Jul 07
Zoetis Adds Devices for Use in Regenerative Medicine Therapies to Growing Equine Portfolio Jun 02 Shareholder Returns 0M3Q GB Pharmaceuticals GB Market 7D 1.9% 0.3% 3.5% 1Y -11.2% -2.0% 10.5%
See full shareholder returns
Return vs Market: 0M3Q underperformed the UK Market which returned 10.5% over the past year.
Price Volatility Is 0M3Q's price volatile compared to industry and market? 0M3Q volatility 0M3Q Average Weekly Movement 3.0% Pharmaceuticals Industry Average Movement 6.7% Market Average Movement 4.8% 10% most volatile stocks in GB Market 10.9% 10% least volatile stocks in GB Market 2.6%
Stable Share Price: 0M3Q has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: 0M3Q's weekly volatility (3%) has been stable over the past year.
About the Company Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives.
Show more Zoetis Inc. Fundamentals Summary How do Zoetis's earnings and revenue compare to its market cap? 0M3Q fundamental statistics Market cap US$74.84b Earnings (TTM ) US$2.43b Revenue (TTM ) US$9.15b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 0M3Q income statement (TTM ) Revenue US$9.15b Cost of Revenue US$2.74b Gross Profit US$6.42b Other Expenses US$3.99b Earnings US$2.43b
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 13, 2025
Earnings per share (EPS) 5.39 Gross Margin 70.09% Net Profit Margin 26.55% Debt/Equity Ratio 126.0%
How did 0M3Q perform over the long term?
See historical performance and comparison Dividends
1.2% Current Dividend Yield When do you need to buy 0M3Q by to receive an upcoming dividend? Zoetis dividend dates Ex Dividend Date Jan 21 2025 Dividend Pay Date Mar 04 2025 Days until Ex dividend 1 day Days until Dividend pay date 41 days
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/01/21 03:23 End of Day Share Price 2025/01/21 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Zoetis Inc. is covered by 43 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Jasper Hellweg Argus Research Company Ishan Majumdar Baptista Research Balaji Prasad Barclays
Show 40 more analysts 
